Mycelium-Based Air Filtration — Enzymatic VOC Degradation in Urban Indoor Environments

Product · HVAC & Energy

Product · InnDex 18 · Evidence provided · High specification risk

Living mycelium composite that passively captures particulates and enzymatically degrades VOCs in indoor air.

A bioengineered material using fungal hyphal networks to filter airborne particulates and secrete oxidative enzymes (laccases, peroxidases) that break down volatile organic compounds. Addresses indoor air quality in dense urban buildings by replacing or supplementing mechanical HVAC filtration with a passive, regenerative biological system. Mechanism is supported by peer-reviewed chemistry, but exists only as prototype installations with no validated performance data from operational buildings.

A bioengineered mycelium composite uses fungal hyphal networks to capture airborne particulates and secrete oxidative enzymes — laccases and peroxidases — that break down common indoor VOCs including formaldehyde, benzene and toluene. The mechanism is supported by peer-reviewed biochemistry, which gives it more scientific grounding than many biophilic air-quality claims, and the passive regenerative character is genuinely differentiated from conventional filter media that saturate over time. In practice, the technology exists only as prototype installations: no field deployment data from operational buildings exists, no validated performance metrics (particulate capture efficiency, VOC degradation kinetics under variable pollutant loads) have been published, and no building code compliance or IAQ certification framework has been established for bioactive filtration materials. Maintaining mycelium viability introduces an environmental conditioning burden — humidity and temperature control needs — and the risks of mold contamination or spore release under stress conditions are uncharacterised. Healthcare, cleanroom and high-contamination-risk environments are explicitly excluded. The concept is worth watching as a supplementary IAQ strategy in well-controlled office or hospitality settings, but enzyme longevity, renewal protocols and building-scale economics all need field data before any specification decision.

Strengths

• Passive operation—no electrical input or active mechanical systems required for core filtration and VOC degradation
• Self-regenerating enzyme production—hyphal networks continuously secrete oxidative enzymes rather than saturating like traditional filters
• Biodegradable/circular material—mycelium is compostable at end-of-life, reducing waste vs. disposable media
• Addresses formaldehyde, benzene, toluene and other common indoor VOCs through enzymatic breakdown, not adsorption

Considerations

• Requires controlled humidity and temperature (mycelium viability)—adds environmental conditioning burden to building system design (moderate)
• Unknown filtration efficiency (particulate capture rate, VOC degradation kinetics) under real indoor conditions; no standardized performance metrics (high)
• Biological material—introduces living organism maintenance, potential for mold contamination or hyphal death if conditions drift (moderate)
• Cannot replace HEPA or sealed mechanical filtration in healthcare, cleanroom, or high-contamination-risk spaces (high)

Risks

• No field deployment data from building-integrated installations—claimed enzyme activity and VOC degradation rates are laboratory-only, not validated in actual indoor air environments with variable humidity, temperature, and pollutant load (critical)
• Regulatory and certification pathway unclear—no established building code compliance, IAQ standards, or third-party certification framework for bioactive filtration materials (high)
• Enzyme kinetics and longevity unknown—how long do laccases/peroxidases remain active? Can enzymes be replenished without material replacement? (high)
• Scale-up and cost unknown—prototype projects do not indicate manufacturing scale, unit cost, or economic viability vs. conventional HVAC filtration (moderate)
• Potential off-gassing or secondary contamination from mycelium metabolic byproducts or spore release under stress conditions not yet characterized (moderate)

Performance

• PM2.5 removal (bench/composite panels): ~75% (unvalidated in-situ)
• VOC reduction claim: 35% (source: AI synthesis, not field trial)
• MDPI study type: CFD numerical simulation only
• Deployment stage: Prototype / pre-commercial

Reality check

MDPI peer-reviewed article exists and describes enzymatic mechanism with CFD modelling. However, primary Atomfair URL cited in source record points to AI-generated synthesis page on lab-equipment supplier domain, not the peer-reviewed paper itself — suggests promotional repackaging rather than direct research communication. Independent search found only two prototype projects (MycoAir London Underground concept, SPLOT Swiss pilot); neither reports completed field validation or performance metrics under real occupancy. No commercial product identified. Claims of passive humidity regulation without mechanical ventilation lack controlled study evidence. Bench-scale results do not translate reliably to HVAC-scale or building-envelope integration without pilot data.

#mycelium #indoor-air-quality #passive-filtration #bioremediation #voc-degradation #prototype

Source